Simona Borštnar

1.5k total citations
42 papers, 356 citations indexed

About

Simona Borštnar is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Simona Borštnar has authored 42 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 17 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Simona Borštnar's work include Advanced Breast Cancer Therapies (12 papers), Cancer Treatment and Pharmacology (12 papers) and Breast Cancer Treatment Studies (8 papers). Simona Borštnar is often cited by papers focused on Advanced Breast Cancer Therapies (12 papers), Cancer Treatment and Pharmacology (12 papers) and Breast Cancer Treatment Studies (8 papers). Simona Borštnar collaborates with scholars based in Slovenia, Italy and France. Simona Borštnar's co-authors include Tanja Čufer, Ivan Vrhovec, Nataša Debeljak, Jožica Červek, Tadeja Matos, Branka Svetic, Aleksander Sadikov, Branko Zakotnik, Rok Blagus and Barbara Gazić and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Simona Borštnar

40 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simona Borštnar Slovenia 12 154 147 95 78 57 42 356
Beverly Spicer United States 3 126 0.8× 113 0.8× 226 2.4× 118 1.5× 39 0.7× 4 435
Yanfeng Liu China 11 163 1.1× 115 0.8× 242 2.5× 54 0.7× 102 1.8× 41 486
J E Nutt United Kingdom 11 160 1.0× 138 0.9× 141 1.5× 94 1.2× 115 2.0× 15 406
Manabu Kato Japan 11 105 0.7× 67 0.5× 127 1.3× 199 2.6× 60 1.1× 45 339
Takae Brewer United States 8 236 1.5× 259 1.8× 135 1.4× 97 1.2× 107 1.9× 12 489
Jelena Urosevic Spain 8 227 1.5× 111 0.8× 221 2.3× 72 0.9× 37 0.6× 10 462
Caipeng Qin China 12 85 0.6× 95 0.6× 202 2.1× 93 1.2× 49 0.9× 41 359
Zhi Yan China 13 80 0.5× 242 1.6× 319 3.4× 50 0.6× 115 2.0× 29 588
Geun Taek Lee United States 14 145 0.9× 73 0.5× 271 2.9× 192 2.5× 25 0.4× 20 461
Kejia Ding China 15 95 0.6× 131 0.9× 247 2.6× 137 1.8× 60 1.1× 25 444

Countries citing papers authored by Simona Borštnar

Since Specialization
Citations

This map shows the geographic impact of Simona Borštnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Borštnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Borštnar more than expected).

Fields of papers citing papers by Simona Borštnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Borštnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Borštnar. The network helps show where Simona Borštnar may publish in the future.

Co-authorship network of co-authors of Simona Borštnar

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Borštnar. A scholar is included among the top collaborators of Simona Borštnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Borštnar. Simona Borštnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gašljević, Gorana, et al.. (2023). Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients—a single institution experience. World Journal of Surgical Oncology. 21(1). 292–292. 3 indexed citations
2.
Borštnar, Simona, et al.. (2023). The association between baseline patient characteristics and alpelisib-induced hyperglycaemia in patients with HR+, HER2-, PIK3CA-mutated metastatic breast cancer.. Journal of Clinical Oncology. 41(16_suppl). e13059–e13059. 1 indexed citations
3.
Miroševič, Špela, Judith B. Prins, Nikola Bešič, et al.. (2023). Symptoms of Anxiety and Depression Among Slovenian Breast Cancer Survivors Post-Treatment During the COVID-19 Pandemic: A Cross-Sectional Study. Slovenian Journal of Public Health. 63(1). 55–62. 2 indexed citations
4.
Tankova, Tsvetalina, Elżbieta Senkus, Simona Borštnar, et al.. (2022). Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer. Cancers. 14(7). 1598–1598. 30 indexed citations
5.
Novak, Metka, et al.. (2022). Effect of combining CBD with standard breast cancer therapeutics. SHILAP Revista de lepidopterología. 4. 100038–100038. 3 indexed citations
6.
Borštnar, Simona, et al.. (2022). Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy. Clinical Breast Cancer. 22(4). e597–e603. 3 indexed citations
7.
Borštnar, Simona, Markéta Palácová, Aleksandra Łacko, et al.. (2022). Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial. Radiology and Oncology. 56(2). 238–247. 2 indexed citations
8.
9.
Borštnar, Simona, et al.. (2020). Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment. Cancers. 12(3). 525–525. 38 indexed citations
10.
Godina, Elena, et al.. (2020). 207P 10-year real-world outcomes with neoadjuvant systemic therapy in non-inflammatory breast cancer. Annals of Oncology. 31. S324–S325. 1 indexed citations
11.
Matos, Erika, et al.. (2020). Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer – results from a real-world setting. Cancer Treatment and Research Communications. 25. 100201–100201. 6 indexed citations
12.
Borštnar, Simona, Ana Blatnik, Andraž Perhavec, et al.. (2019). Smernice diagnostike in zdravljenja raka dojk. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Marinko, Tanja, et al.. (2018). Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer. Radiology and Oncology. 52(2). 204–212. 13 indexed citations
14.
Gazić, Barbara, et al.. (2014). Prognostic value of routinely determined tumor infiltrating lymphocytes in triple-negative breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 1125–1125. 3 indexed citations
15.
16.
Borštnar, Simona, et al.. (2009). High levels of uPA and PAI-1 predict a good response to anthracyclines. Breast Cancer Research and Treatment. 121(3). 615–624. 20 indexed citations
17.
Gazić, Barbara, Jože Pižem, Matej Bračko, et al.. (2008). S‐phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer – a multivariate study of 770 patients. Cytopathology. 19(5). 294–302. 16 indexed citations
18.
Borštnar, Simona, Ivan Vrhovec, Branka Svetic, & Tanja Čufer. (2002). Prognostic Value of the Urokinase-Type Plasminogen Activator, and its Inhibitors and Receptor in Breast Cancer Patients. Clinical Breast Cancer. 3(2). 138–146. 25 indexed citations
19.
Matos, Tadeja, et al.. (2000). Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach). International Journal of Radiation Oncology*Biology*Physics. 46(2). 403–409. 17 indexed citations
20.
Červek, Jožica, et al.. (1998). Invasive Bladder Cancer: Our Experience With Bladder Sparing Approach. International Journal of Radiation Oncology*Biology*Physics. 41(2). 273–278. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beverly Spicer Breakdown of academic impact, for papers by Yanfeng Liu Breakdown of academic impact, for papers by J E Nutt Breakdown of academic impact, for papers by Manabu Kato Breakdown of academic impact, for papers by Takae Brewer Breakdown of academic impact, for papers by Jelena Urosevic Breakdown of academic impact, for papers by Caipeng Qin Breakdown of academic impact, for papers by Zhi Yan Breakdown of academic impact, for papers by Geun Taek Lee Breakdown of academic impact, for papers by Kejia Ding
Rankless by CCL
2026